Literature DB >> 9250636

Clinical trial of induced hypothermia in comatose survivors of out-of-hospital cardiac arrest.

S A Bernard1, B M Jones, M K Horne.   

Abstract

STUDY
OBJECTIVE: To examine the effects of moderate hypothermia (33 degrees C), induced by surface cooling in the ED and maintained for 12 hours in the ICU, on patients with anoxic brain injury after out-of-hospital cardiac arrest.
METHODS: We conducted the study in a teaching hospital in Melbourne, Victoria, Australia. Participants were 22 adults who remained unconscious after return of spontaneous circulation following out-of-hospital cardiac arrest. This treatment group was studied prospectively, and a control group of 22 similar patients was studied by retrospective chart review. Moderate hypothermia (33 degrees C) was induced in the ED by means of surface cooling and maintained for 12 hours in the ICU with rewarming to normothermia over 6 hours; control patients were maintained at normothermia.
RESULTS: There were no significant adverse effects of induced hypothermia. Cardiovascular changes included decreased pulse rate, but there were no significant differences in mean arterial blood pressure between the two groups. Small increases in serum potassium and decreases in pH at 18 hours in the hypothermic patients compared with normothermic controls were of no clinical significance. There were no septic complications. There was a significant increase in the number of patients with good outcome (Glasgow Outcome Coma Scale category 1 or 2) with induced hypothermia (11 of 22, versus 3 of 22 for normothermic controls; P<.05), and the mortality rate was significantly lower (10 of 22 versus 17 of 22; P<.05).
CONCLUSION: Compared with historical normothermic controls, outcome was significantly improved and there was no increase in complications when moderate hypothermia was induced in comatose survivors of out-of-hospital cardiac arrest and maintained for 12 hours. Larger, prospective, randomized, controlled studies of induced moderate hypothermia in comatose survivors of out-of-hospital cardiac arrest are warranted.

Entities:  

Mesh:

Year:  1997        PMID: 9250636     DOI: 10.1016/s0196-0644(97)70133-1

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  50 in total

1.  Mass Effect with Cerebral Infarction.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-07       Impact factor: 3.598

2.  Utilization of hyperbaric oxygen therapy and induced hypothermia after hydrogen sulfide exposure.

Authors:  Mir J Asif; Matthew C Exline
Journal:  Respir Care       Date:  2011-10-12       Impact factor: 2.258

Review 3.  [Therapeutic hypothermia after cardiac arrest].

Authors:  E Popp; F Sterz; B W Böttiger
Journal:  Anaesthesist       Date:  2005-02       Impact factor: 1.041

Review 4.  [Controlled mild-to-moderate hypothermia in the intensive care unit].

Authors:  A Brüx; A R J Girbes; K H Polderman
Journal:  Anaesthesist       Date:  2005-03       Impact factor: 1.041

5.  [Therapeutic hypothermia after cardiopulmonary resuscitation - pro and con].

Authors:  Christoph Pechlaner; Michael Joannidis
Journal:  Wien Med Wochenschr       Date:  2008

Review 6.  Therapeutic hypothermia for cardiac arrest: a practical approach.

Authors:  David B Seder; Salam Jarrah
Journal:  Curr Neurol Neurosci Rep       Date:  2008-11       Impact factor: 5.081

7.  Therapeutic hypothermia after cardiac arrest: performance characteristics and safety of surface cooling with or without endovascular cooling.

Authors:  Alexander C Flint; J Claude Hemphill; David C Bonovich
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

8.  New Developments in Cardiac Arrest Management.

Authors:  Matthias L Riess
Journal:  Adv Anesth       Date:  2016

Review 9.  The use of pre-hospital mild hypothermia after resuscitation from out-of-hospital cardiac arrest.

Authors:  Francis Kim; Michele Olsufka; Graham Nichol; Michael K Copass; Leonard A Cobb
Journal:  J Neurotrauma       Date:  2009-03       Impact factor: 5.269

Review 10. 

Authors:  J P Nolan; C D Deakin; J Soar; B W Böttiger; G Smith; M Baubin; B Dirks; V Wenzel
Journal:  Notf Rett Med       Date:  2006-02-01       Impact factor: 0.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.